BiotechTube
Home/Inhalon Biopharma/John Whelan
JW

John Whelan

President, Chief Executive Officer and Director

Inhalon Biopharma

Therapeutic Areas

Infectious DiseaseRespiratory

Inhalon Biopharma Pipeline

DrugIndicationPhase
IN-006COVID-19 (SARS-CoV-2)Phase 1b
IN-002Respiratory Syncytial Virus (RSV)Pre-IND
IN-007COVID-19 (SARS-CoV-2)Preclinical

Leadership Team at Inhalon Biopharma

SL
Sam Lai, PhD
Founder, Chief Scientific Officer and Director
TM
Thomas Moench, MD
Vice President, Clinical
View full Inhalon Biopharma profile